JPS6438086A - Mevalonic acid derivative and manufacture - Google Patents
Mevalonic acid derivative and manufactureInfo
- Publication number
- JPS6438086A JPS6438086A JP63169164A JP16916488A JPS6438086A JP S6438086 A JPS6438086 A JP S6438086A JP 63169164 A JP63169164 A JP 63169164A JP 16916488 A JP16916488 A JP 16916488A JP S6438086 A JPS6438086 A JP S6438086A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- manufacture
- acid derivative
- mevalonic acid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical class OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- MMCOUVMKNAHQOY-UHFFFAOYSA-N carbonoperoxoic acid Chemical class OOC(O)=O MMCOUVMKNAHQOY-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873722809 DE3722809A1 (de) | 1987-07-10 | 1987-07-10 | 3-desmethyl-4-fluor-mevalonsaeurederivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung und zwischenprodukte |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6438086A true JPS6438086A (en) | 1989-02-08 |
Family
ID=6331294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63169164A Pending JPS6438086A (en) | 1987-07-10 | 1988-07-08 | Mevalonic acid derivative and manufacture |
Country Status (19)
Country | Link |
---|---|
US (1) | US4898868A (ja) |
EP (1) | EP0302253B1 (ja) |
JP (1) | JPS6438086A (ja) |
KR (1) | KR890002084A (ja) |
AT (1) | ATE87916T1 (ja) |
AU (1) | AU612665B2 (ja) |
CA (1) | CA1319363C (ja) |
DE (2) | DE3722809A1 (ja) |
DK (1) | DK383388A (ja) |
ES (1) | ES2054738T3 (ja) |
FI (1) | FI883250A (ja) |
HU (1) | HU205071B (ja) |
IE (1) | IE62528B1 (ja) |
IL (1) | IL87037A (ja) |
NO (1) | NO172537C (ja) |
NZ (1) | NZ225345A (ja) |
PH (1) | PH26770A (ja) |
PT (1) | PT87930B (ja) |
ZA (1) | ZA884922B (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
DE3925636A1 (de) * | 1989-08-03 | 1991-02-07 | Bayer Ag | Imino-substituierte pyridine |
US5093363A (en) * | 1989-08-22 | 1992-03-03 | Shionogi & Co., Ltd. | 2,4,6-substituted phenol derivatives |
DE3929913A1 (de) * | 1989-09-08 | 1991-04-04 | Hoechst Ag | 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte |
IT1237792B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
US5149834A (en) * | 1990-03-07 | 1992-09-22 | Fujirebio Inc. | 4-hydroxytetrahydropyran-2-one derivatives |
GB9013699D0 (en) * | 1990-06-20 | 1990-08-08 | Rhone Poulenc Sante | New process |
CN102086184A (zh) * | 2011-03-03 | 2011-06-08 | 上海应用技术学院 | 5位氟取代的4-羟基-3,4,5,6-四氢-2h-吡喃-2-酮类化合物及其制备方法 |
CN102153463A (zh) * | 2011-03-03 | 2011-08-17 | 上海应用技术学院 | 4位氟取代的3,5-二羟基羧酸化合物及其制备方法 |
CN104262248A (zh) * | 2014-09-03 | 2015-01-07 | 上海应用技术学院 | 5位取代的4,4-二氟-3,5-二羟基羧酸及其金属盐的制备方法 |
CN104351190A (zh) * | 2014-10-23 | 2015-02-18 | 上海应用技术学院 | 4位偕二氟取代的3,5二羟基羧酸化合物在害虫防治中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53147073A (en) * | 1977-05-24 | 1978-12-21 | Sankyo Co Ltd | Mevalonolactone derivatives |
US4562258A (en) * | 1982-02-04 | 1985-12-31 | Findlay John W A | 6-[3-Amino-1-(4-tolyl)prop-1E-enyl]pyridine-2-carboxylic acid derivatives having antihistaminic activity |
US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
DE3530797A1 (de) * | 1985-08-29 | 1987-03-05 | Hoechst Ag | 3-desmethyl-mevalonsaeurederivate, verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen, ihre verwendung sowie zwischenprodukte |
EP0216127B1 (de) * | 1985-08-29 | 1990-09-26 | Hoechst Aktiengesellschaft | 6-Phenoxymethyl-4-hydroxytetrahydropyran-2-one, Verfahren zu ihrer Herstellung, ihre Verwendung als Arzneimittel, pharmazeutische Präparate und Zwischenprodukte |
EP0217092B1 (de) * | 1985-08-29 | 1990-03-28 | Hoechst Aktiengesellschaft | 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte |
DE3530798A1 (de) * | 1985-08-29 | 1987-03-05 | Hoechst Ag | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
US4812460A (en) * | 1986-03-25 | 1989-03-14 | Boehringer Ingelheim Pharmaceutical, Inc. | 3-[2-(3',5'-di-t-butyl-4'-hydroxyphenyl)ethenyl]pyridine |
DE3632893A1 (de) * | 1986-09-27 | 1988-04-07 | Hoechst Ag | 4-(r)-hydroxy-6(s)-arylthiomethyl-tetrahydropyran-2-one, deren entsprechende sulfoxide und sulfone, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
PT87929B (pt) * | 1987-07-10 | 1995-03-01 | Hoechst Ag | Processo para a preparacao de derivados de acido 3-desmetil-mevalonico e de composicoes farmaceuticas que os contem |
DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
DE3832570A1 (de) * | 1988-09-24 | 1990-03-29 | Hoechst Ag | 7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte |
US6622253B2 (en) * | 2001-08-02 | 2003-09-16 | Scientific-Atlanta, Inc. | Controlling processor clock rate based on thread priority |
-
1987
- 1987-07-10 DE DE19873722809 patent/DE3722809A1/de not_active Withdrawn
-
1988
- 1988-07-07 ES ES88110834T patent/ES2054738T3/es not_active Expired - Lifetime
- 1988-07-07 EP EP88110834A patent/EP0302253B1/de not_active Expired - Lifetime
- 1988-07-07 PT PT87930A patent/PT87930B/pt not_active IP Right Cessation
- 1988-07-07 FI FI883250A patent/FI883250A/fi not_active Application Discontinuation
- 1988-07-07 DE DE8888110834T patent/DE3880041D1/de not_active Expired - Fee Related
- 1988-07-07 AT AT88110834T patent/ATE87916T1/de not_active IP Right Cessation
- 1988-07-08 PH PH37203A patent/PH26770A/en unknown
- 1988-07-08 DK DK383388A patent/DK383388A/da not_active Application Discontinuation
- 1988-07-08 US US07/216,752 patent/US4898868A/en not_active Expired - Fee Related
- 1988-07-08 NZ NZ225345A patent/NZ225345A/en unknown
- 1988-07-08 IL IL8703788A patent/IL87037A/en not_active IP Right Cessation
- 1988-07-08 CA CA000571559A patent/CA1319363C/en not_active Expired - Fee Related
- 1988-07-08 JP JP63169164A patent/JPS6438086A/ja active Pending
- 1988-07-08 IE IE210088A patent/IE62528B1/en not_active IP Right Cessation
- 1988-07-08 HU HU883595A patent/HU205071B/hu not_active IP Right Cessation
- 1988-07-08 ZA ZA884922A patent/ZA884922B/xx unknown
- 1988-07-08 NO NO883074A patent/NO172537C/no unknown
- 1988-07-08 AU AU18883/88A patent/AU612665B2/en not_active Ceased
- 1988-07-09 KR KR1019880008549A patent/KR890002084A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1888388A (en) | 1989-01-12 |
NO883074D0 (no) | 1988-07-08 |
NO172537C (no) | 1993-08-04 |
ES2054738T3 (es) | 1994-08-16 |
NO172537B (no) | 1993-04-26 |
NZ225345A (en) | 1991-05-28 |
EP0302253A1 (de) | 1989-02-08 |
DK383388A (da) | 1989-01-11 |
PH26770A (en) | 1992-09-28 |
HUT51221A (en) | 1990-04-28 |
CA1319363C (en) | 1993-06-22 |
PT87930A (pt) | 1989-06-30 |
FI883250A (fi) | 1989-01-11 |
NO883074L (no) | 1989-01-11 |
AU612665B2 (en) | 1991-07-18 |
ZA884922B (en) | 1989-01-17 |
PT87930B (pt) | 1995-03-01 |
US4898868A (en) | 1990-02-06 |
ATE87916T1 (de) | 1993-04-15 |
EP0302253B1 (de) | 1993-04-07 |
IE62528B1 (en) | 1995-02-08 |
KR890002084A (ko) | 1989-04-08 |
IL87037A0 (en) | 1988-12-30 |
DE3722809A1 (de) | 1989-01-19 |
IL87037A (en) | 1995-03-30 |
DE3880041D1 (de) | 1993-05-13 |
DK383388D0 (da) | 1988-07-08 |
IE882100L (en) | 1989-01-10 |
HU205071B (en) | 1992-03-30 |
FI883250A0 (fi) | 1988-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2024A (en) | 3-Demethyl-4-fluoro-mevalonic-acid derivatives process for their preparation pharmaceutical preparations based on those compounds their use and intermediates | |
IL91753A0 (en) | 7-substituted derivatives of 3,5-dihydroxyhept-6-ynoic acid,a process for the preparation thereof and pharmaceutical compositions containing them | |
GR3004925T3 (ja) | ||
JPS6438086A (en) | Mevalonic acid derivative and manufacture | |
DE3361757D1 (en) | Salicylic-acid derivatives, process for their preparation, pharmaceutical preparations based on these compounds and their use | |
AU1264488A (en) | Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds | |
ZA826453B (en) | Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds | |
IL91212A0 (en) | 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof,a process for the preparation thereof and pharmaceutical compositions containing them |